PMID- 37652299
OWN - NLM
STAT- MEDLINE
DCOM- 20231128
LR  - 20240205
IS  - 1535-7732 (Electronic)
IS  - 1051-0443 (Linking)
VI  - 34
IP  - 12
DP  - 2023 Dec
TI  - Decreased Bleeding-Related Adverse Events Using Track Embolization with Gelatin 
      Sponge Slurry after Percutaneous Liver Biopsy: A Propensity Score-Matched Study.
PG  - 2128-2136
LID - S1051-0443(23)00646-2 [pii]
LID - 10.1016/j.jvir.2023.08.034 [doi]
AB  - PURPOSE: To evaluate the effectiveness of track embolization using gelatin sponge 
      slurry in percutaneous ultrasound (US)-guided liver biopsy. MATERIALS AND 
      METHODS: Among the 543 patients who underwent percutaneous US-guided liver 
      biopsies between September 2018 and August 2021, 338 who did not undergo track 
      embolization and 105 who underwent track embolization were included in the 
      analysis. All procedures were performed with 18-gauge coaxial core biopsy 
      needles. Patients' laboratory data were reviewed. Patients in both groups were 
      subdivided into the following 2 groups: (a) those with targeted biopsy for a 
      focal liver lesion and (b) those with nontargeted biopsy for a liver parenchyma. 
      Moreover, postbiopsy events, such as transfusion and transarterial embolization, 
      were assessed. To minimize selection bias, propensity score matching (PSM) was 
      performed. RESULTS: After PSM, all factors that could affect bleeding risk were 
      well-matched and well-balanced between the 2 groups (P > .474). In the non-track 
      embolization group, 17 (16.2%) patients experienced major or minor 
      bleeding-related adverse events (AEs). In contrast, in the track embolization 
      group, only 5 (4.8%) patients experienced major or minor bleeding-related AEs, 
      which was significantly lower than that in the non-track embolization group (P = 
      .007). All 5 (4.8%) cases of major bleeding-related AEs were observed in the 
      non-track embolization group (P = .024). CONCLUSIONS: In this study, a 
      retrospective analysis was performed using PSM for percutaneous US-guided liver 
      biopsy. Track embolization using gelatin sponge slurry is significantly superior 
      in the prevention of bleeding-related AEs after US-guided liver biopsy.
CI  - Copyright (c) 2023 SIR. Published by Elsevier Inc. All rights reserved.
FAU - Koh, Sungho
AU  - Koh S
AD  - Department of Radiology, Pusan National University Hospital, Pusan National 
      University School of Medicine, Pusan National University, Busan, Republic of 
      Korea.
FAU - Kwon, Hoon
AU  - Kwon H
AD  - Department of Radiology, Pusan National University Hospital, Pusan National 
      University School of Medicine, Pusan National University, Busan, Republic of 
      Korea. Electronic address: khoon2r@gmail.com.
FAU - Hwangbo, Lee
AU  - Hwangbo L
AD  - Department of Radiology, Pusan National University Hospital, Pusan National 
      University School of Medicine, Pusan National University, Busan, Republic of 
      Korea.
FAU - Kim, Chang Won
AU  - Kim CW
AD  - Department of Radiology, Pusan National University Hospital, Pusan National 
      University School of Medicine, Pusan National University, Busan, Republic of 
      Korea.
FAU - Kim, Suk
AU  - Kim S
AD  - Department of Radiology, Pusan National University Hospital, Pusan National 
      University School of Medicine, Pusan National University, Busan, Republic of 
      Korea.
FAU - Hong, Seung Baek
AU  - Hong SB
AD  - Department of Radiology, Pusan National University Hospital, Pusan National 
      University School of Medicine, Pusan National University, Busan, Republic of 
      Korea.
LA  - eng
PT  - Journal Article
DEP - 20230829
PL  - United States
TA  - J Vasc Interv Radiol
JT  - Journal of vascular and interventional radiology : JVIR
JID - 9203369
RN  - 9000-70-8 (Gelatin)
SB  - IM
MH  - Female
MH  - Humans
MH  - *Gelatin/adverse effects
MH  - Retrospective Studies
MH  - Propensity Score
MH  - *Hemorrhage/etiology/prevention & control
MH  - Liver/diagnostic imaging/pathology
MH  - Image-Guided Biopsy/adverse effects/methods
EDAT- 2023/09/01 00:41
MHDA- 2023/11/28 06:42
CRDT- 2023/08/31 19:28
PHST- 2023/05/11 00:00 [received]
PHST- 2023/08/17 00:00 [revised]
PHST- 2023/08/21 00:00 [accepted]
PHST- 2023/11/28 06:42 [medline]
PHST- 2023/09/01 00:41 [pubmed]
PHST- 2023/08/31 19:28 [entrez]
AID - S1051-0443(23)00646-2 [pii]
AID - 10.1016/j.jvir.2023.08.034 [doi]
PST - ppublish
SO  - J Vasc Interv Radiol. 2023 Dec;34(12):2128-2136. doi: 10.1016/j.jvir.2023.08.034. 
      Epub 2023 Aug 29.